Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%

Cutis

Volumn 79, Issue 4, 2007, Pages 317-321

  Colón, Luz E ^a   Johnson, Lori A ^a   Gottschalk, Ronald W ^a  

^a Galderma Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; DERMATOLOGICAL AGENT; DICARBOXYLIC ACID; METRONIDAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ERUPTION; FEMALE; GEL; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; ROSACEA; SINGLE BLIND PROCEDURE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DRUG ERUPTIONS; FEMALE; GELS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; ROSACEA; SINGLE-BLIND METHOD;

EID: 34248344667     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rebora A. The management of rosacea. Am J Clin Dematol. 2002;3:489-496.
2. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother, 2004;5:5-13.
3. Buechner SA. Rosacea: an update. Dermatology. 2005; 210:100-108.
4. Survey shows facial disorder hurts more than appearance [press release]. Barrington, Ill: The National Rosacea Society; February 20, 2006.
5. Gupta AK, Chaudhry M. Topical metronidazole for rosacea. Skin Therapy Lett. 2002;7(1):1-3, 6.
6. Aronson IK, Rumsfield JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm. 1987;21:346-351.
7. Wolf JE Jr, Kerrouche N, Arsonnaud S. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis. 2006;77(suppl 4):3-11.
8. Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea. Arch Dematol. 1987;123: 609-614.
9. Espagne E, Guillaume JC, Archimbaud A, et al. Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea [in French]. Ann Dermatol Venereol. 1993;120:129-133.
10. Breneman DL, Stewart D, Hevia O, et al. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis. 1998;61:44-47.
11. Drake L, Leyden J, Lucky A, et al. Evaluation of topical metronidazole cream in rosacea. In: Abstracts of the American Academy of Dermatology 55th Annual Meeting; San Francisco, Calif: March 21-26, 1998. Abstract P65.
12. Bitar A, Bourgouin J, Dore N, et al. A double-blind randomised study of metronidazole (Flagyl) 1% cream in the treatment of acne rosacea: a placebo-controlled study. Drug Invest. 1990;2:242-248.
13. Bjerke J, Nyfors A, Austad J, et al. Metronidazole (Elyzol) 1% cream v. placebo cream in the treatment of rosacea. Clin Trials J. 1989;26:187-194.
14. Jorizzo JL, Lebwohl M, Tobey RE. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol. 1998;39:502-504.
15. Nielsen PG. A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br J Dermatol. 1983;109:63-65.
16. Bjerke R, Fyrand O, Graupe K. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. Acta Derm Venereol. 1999;79:456-459.
17. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol. 1999;40(6 pt 1):961-965.
18. Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol. 2003;139:1444-1450.
19. Green B. Regional and individual differences in cutaneous sensitivity to chemical irritants: capsaicin and menthol. J Toxicol Cutaneous Ocul Toxicol. 1996;15: 277-295.
20. Robinson MK. Intra-individual variations in acute and cumulative skin irritation responses. Contact Dermatitis. 2001;45:75-83.
21. Ziel K, Yelverton CB, Balkrishnan R, et al. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. J Drugs Dermatol. 2005;4:727-731.
22. Queille-Roussel C, Poncet M, Mesaros S, et al. Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel. Clin Ther. 2001;23:205-212.
23. Caron D, Sorba V, Clucas A, et al. Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments. J Am Acad Dermatol. 1997;36 (6 pt 2):S113-S115.
24. Dow G, Basu S. A novel aqueous metronidazole 1% gel with hydrosolubilizing agents (HSA-3). Cutis. 2006;77(suppl 4):18-26.